Evidence map›Paper›PMID 42718542›Full record

ArticleOpen research Europe2025

Toward a unified approach: Considerations for bioinformatic and sequencing activities & data in wastewater surveillance of biologic public health threats.

Fotis Psomopoulos, Colman O'Cathail, Natasa Anastasiadou, Clementina Cocuzza, Wim L Cuypers, Olateju Idowu, Konstantinos Kyritsis, Katharina B Lauer, Marialuisa Lavitrano, Gabriele Leoni and 16 more

Abstract readLetter
In one paragraph

Article in Open research Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Fotis PsomopoulosInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.ORCID https://orcid.org/0000-0002-0222-4273
Colman O'CathailEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, UK.
Natasa AnastasiadouInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.ORCID https://orcid.org/0009-0003-2908-7656
Clementina CocuzzaDepartment of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.ORCID https://orcid.org/0000-0001-6166-1134
Wim L CuypersAdrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium.
Olateju IdowuUniversity College Dublin School of Medicine, Dublin, Leinster, Ireland.
Konstantinos KyritsisInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Katharina B LauerAirfinity Ltd, London, UK.
Marialuisa LavitranoDepartment of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.ORCID https://orcid.org/0000-0003-4852-1318
Gabriele LeoniEuropean Commission, Joint Research Centre (JRC), Ispra, 21027, Italy.ORCID https://orcid.org/0000-0002-4899-5284
Ju-Ling LiuMcGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Québec, Canada.ORCID https://orcid.org/0000-0002-5366-7461
Guerrino MacoriSchool of Biology and Environmental Science, University College Dublin, Dublin, Leinster, Ireland.
Giulio MannaràDepartment of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
Douglas G ManuelOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0003-0912-0845
Marianna MartinelliDepartment of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.ORCID https://orcid.org/0000-0003-2273-6986
Rosario MusumeciDepartment of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.ORCID https://orcid.org/0000-0003-0143-3601
Aitana NevesSIB, Swiss Institute of Bioinformatics, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-3984-6842
Nikos PechlivanisInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.ORCID https://orcid.org/0000-0003-2502-612X
Mauro PetrilloSeidor Italy srl, Milano, Italy.ORCID https://orcid.org/0000-0002-6782-4704
Jiannis RagoussisMcGill Genome Centre, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Québec, Canada.ORCID https://orcid.org/0000-0002-8515-0934
Nadim RahmanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, UK.
Katarina Öjefors StarkInst for Immunology, Genetics, and Pathology, SciLifeLab Data Centre, Science for Life Laboratory, Uppsala, Sweden.ORCID https://orcid.org/0000-0001-7970-7778
Mathew ThomsonOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0002-8155-3840
Matthew J WadeChief Data Officer Group, UK Health Security Agency, London, UK.ORCID https://orcid.org/0000-0001-9824-7121
Michael WrightAirfinity Ltd, London, UK.
ELIXIR Wastewater Surveillance Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic technologies such as PCR and next-generation sequencing (NGS) have greatly advanced public health surveillance, especially during COVID-19, by enabling detailed tracking of pathogen spread, origins, and variants. While PCR is vital for targeted detection, falling NGS costs have made large-scale, high-throughput sequencing more feasible, supporting broader pathogen monitoring-including the detection of vaccine escape variants and new strains. Applying NGS to wastewater offers valuable population-level insights but faces challenges such as variable sample complexity, the need for skilled staff, suitable platforms, and robust IT infrastructure. Although there are currently a lot of efforts towards defining guidelines for sampling, analysis, and integrating wastewater data into public health policy, such as the recently published International Cookbook for Wastewater Practitioners, they often lack universal applicability, emphasizing the analytical approaches in favour of the NGS-based approaches. However, standardising protocols for sampling, sequencing, and analysis is crucial to ensure reliable, comparable data across surveillance systems worldwide. Pilot studies and continuous refinement are recommended to overcome implementation hurdles and fully realise the benefits of NGS in wastewater surveillance. This work attempts to outline these challenges and opportunities across the entire wastewater surveillance workflow, from data generation to reporting, and provide some concrete suggestions and considerations across the spectrum of activities. We further highlight that the infrastructure, funding and government-policy context in which surveillance operates acts as an enabling condition for these activities, and that technical standardisation alone is unlikely to deliver durable, comparable surveillance in its absence.

Indexed as

considerationshigh-throughput sequencing datarecommendationswastewater-based surveillance

Identifiers

PMID42718542
PMCPMC13550913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.